Literature DB >> 26034339

Optically Triggered Immune Response through Photocaged Oligonucleotides.

Jeane M Govan1, Douglas D Young1, Mark O Lively2, Alexander Deiters3.   

Abstract

Bacterial and viral CpG oligonculeotides are unmethylated cytosine-phosphate-guanosine dinucleotide sequences and trigger an innate immune response through activation of the toll-like receptor 9 (TLR9). We have developed synthetic photocaged CpGs via site-specific incorporation of nitropiperonyloxymethyl (NPOM)-caged thymidine residues. These oligonucleotides enable the optical control of TLR9 function and thereby provide light-activation of an immune response. We provide a proof-of-concept model by applying a reporter assay in live cells and by quantification of endogenous production of interleukin 6.

Entities:  

Keywords:  immune response; light-activation; oligonucleotide synthesis; photocaged nucleotides; toll-like receptors

Year:  2015        PMID: 26034339      PMCID: PMC4448726          DOI: 10.1016/j.tetlet.2015.01.165

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  31 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

Review 2.  Optical control of protein function through unnatural amino acid mutagenesis and other optogenetic approaches.

Authors:  Austin S Baker; Alexander Deiters
Journal:  ACS Chem Biol       Date:  2014-05-21       Impact factor: 5.100

3.  CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults.

Authors:  Curtis L Cooper; Heather L Davis; Jonathan B Angel; Mary Lou Morris; Sue M Elfer; Isabelle Seguin; Arthur M Krieg; D William Cameron
Journal:  AIDS       Date:  2005-09-23       Impact factor: 4.177

4.  Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers.

Authors:  Dianna Rynkiewicz; Melinda Rathkopf; Iain Sim; A Thomas Waytes; Robert J Hopkins; Lallan Giri; Deborah DeMuria; Janet Ransom; James Quinn; Gary S Nabors; Carl J Nielsen
Journal:  Vaccine       Date:  2011-05-30       Impact factor: 3.641

5.  Efficient in vivo priming by vaccination with recombinant NY-ESO-1 protein and CpG in antigen naive prostate cancer patients.

Authors:  Julia Karbach; Antje Neumann; Akin Atmaca; Claudia Wahle; Kathrin Brand; Lotta von Boehmer; Alexander Knuth; Armin Bender; Gerd Ritter; Lloyd J Old; Elke Jäger
Journal:  Clin Cancer Res       Date:  2010-12-16       Impact factor: 12.531

Review 6.  Toll-like receptor 9 agonists as cancer therapeutics.

Authors:  Udo Holtick; Max E Scheulen; Michael S von Bergwelt-Baildon; Martin R Weihrauch
Journal:  Expert Opin Investig Drugs       Date:  2011-01-22       Impact factor: 6.206

Review 7.  CpG DNA as a vaccine adjuvant.

Authors:  Christian Bode; Gan Zhao; Folkert Steinhagen; Takeshi Kinjo; Dennis M Klinman
Journal:  Expert Rev Vaccines       Date:  2011-04       Impact factor: 5.217

8.  Photochemical regulation of restriction endonuclease activity.

Authors:  Douglas D Young; Jeane M Govan; Mark O Lively; Alexander Deiters
Journal:  Chembiochem       Date:  2009-07-06       Impact factor: 3.164

9.  Optochemical control of deoxyoligonucleotide function via a nucleobase-caging approach.

Authors:  Qingyang Liu; Alexander Deiters
Journal:  Acc Chem Res       Date:  2013-08-28       Impact factor: 22.384

10.  Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments.

Authors:  Parviz Ahmad-Nejad; Hans Häcker; Mark Rutz; Stefan Bauer; Ramunas M Vabulas; Hermann Wagner
Journal:  Eur J Immunol       Date:  2002-07       Impact factor: 5.532

View more
  8 in total

Review 1.  Optochemical Control of Biological Processes in Cells and Animals.

Authors:  Nicholas Ankenbruck; Taylor Courtney; Yuta Naro; Alexander Deiters
Journal:  Angew Chem Int Ed Engl       Date:  2018-02-01       Impact factor: 15.336

2.  A Light-Controlled TLR4 Agonist and Selectable Activation of Cell Subpopulations.

Authors:  Lalisa Stutts; Aaron P Esser-Kahn
Journal:  Chembiochem       Date:  2015-06-26       Impact factor: 3.164

3.  Photoactivatable Circular Caged Oligonucleotides for Transcriptome In Vivo Analysis (TIVA).

Authors:  Linlin Yang; Dora von Trentini; HyunBum Kim; Jai-Yoon Sul; James H Eberwine; Ivan J Dmochowski
Journal:  ChemPhotoChem       Date:  2021-06-23

4.  Efficient Synthesis of Light-Triggered Circular Antisense Oligonucleotides Targeting Cellular Protein Expression.

Authors:  Linlin Yang; Hyun Bum Kim; Jai-Yoon Sul; Sean B Yeldell; James H Eberwine; Ivan J Dmochowski
Journal:  Chembiochem       Date:  2018-04-17       Impact factor: 3.164

5.  Light Guided In-vivo Activation of Innate Immune Cells with Photocaged TLR 2/6 Agonist.

Authors:  Keun Ah Ryu; Bethany McGonnigal; Troy Moore; Tawnya Kargupta; Rock J Mancini; Aaron P Esser-Kahn
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

6.  Chemical optogenetic modulation of inflammation and immunity.

Authors:  Bibudha Parasar; Pamela V Chang
Journal:  Chem Sci       Date:  2016-10-21       Impact factor: 9.825

Review 7.  Photochemical modifications for DNA/RNA oligonucleotides.

Authors:  Amirrasoul Tavakoli; Jung-Hyun Min
Journal:  RSC Adv       Date:  2022-02-24       Impact factor: 3.361

8.  Conditionally Controlling Human TLR2 Activity via Trans-Cyclooctene Caged Ligands.

Authors:  Michel J van de Graaff; Timo Oosenbrug; Mikkel H S Marqvorsen; Clarissa R Nascimento; Mark A R de Geus; Bénédicte Manoury; Maaike E Ressing; Sander I van Kasteren
Journal:  Bioconjug Chem       Date:  2020-06-08       Impact factor: 4.774

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.